test

Sven H. Borho

@Orbimed Advisors Llc

Latest period2024 - Q3ReportedManaged Assets$5.504BTotal holdings113
Assets growth rate8.67%Assets growth rate (2-Q avg)0.72%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Orbimed Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 113 positions.

Assets under management

The assets under management (AUM) of Orbimed Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 5.504B in assets, with a quarterly growth rate of 8.67% and a 2-quarter average growth rate of 0.72%. The portfolio is managed by Sven H. Borho, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Increased 44.33%
2.28%
$125.452M
1.004M shares@ $124.89 avg price
SYKStryker Corporation
Recent Activity
Increased 28.03%
2.27%
$124.418M
344,400 shares@ $361.26 avg price
UNHUnitedhealth Group Inc
Recent Activity
Increased 59.83%
1.91%
$104.658M
179,000 shares@ $584.68 avg price
AMGNAmgen Inc
Recent Activity
Increased 87.03%
1.48%
$81.294M
252,300 shares@ $322.21 avg price
ITGRInteger Hldgs Corp
Recent Activity
Increased 64.66%
1.36%
$74.75M
575,000 shares@ $130.0 avg price
RNAAvidity Biosciences Inc
Recent Activity
Increased 62.05%
0.96%
$52.581M
1.145M shares@ $45.94 avg price
SIBNSi-bone Inc
Recent Activity
Increased 2.18%
0.91%
$49.71M↑ Call
3.556M shares@ $13.99 avg price
REGNRegeneron Pharmaceuticals
Recent Activity
Increased 98.25%
0.87%
$47.516M
45,200 shares@ $1051.24 avg price
EXASExact Sciences Corp
Recent Activity
Increased 1.11%
0.85%
$46.309M
679,816 shares@ $68.13 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 5.69%
0.66%
$35.883M
911,420 shares@ $39.37 avg price